Fabuzest 40 MG Tablet

Manufactured byUnichem Laboratories Ltd.
ContainsFebuxostat
Description

Fabuzest 40 MG Tablet is an antigout agent which is used to prevent gout attacks by reducing the uric acid production. It should be started at low doses and increase gradually. It is not recommended in the patients with the known history of allergy.

Side effects

Major & minor side effects for Fabuzest 40 MG Tablet

  • Abdominal pain
  • Blurred vision
  • Chest discomfort
  • Fast heartbeat
  • Itching or rash
  • Pale skin
  • Yellow colored eyes or skin
  • Decreased interest in sexual intercourse
  • Unexpected weight gain or loss
  • Throat irritation

Uses of Fabuzest 40 MG Tablet

What is it prescribed for?

  • Gout
Read More
Concerns

Commonly asked questions

  • Onset of action
    The peak effect of this medicine can be observed in 1 to 1.5 hours.
  • Duration of effect
    The effect of this medicine lasts for an average duration of 15 to 24 hours.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is not recommended for use during pregnancy unless absolutely necessary. Consult your doctor about the potential benefits and risks before deciding to take this medicine.
  • Usage while breast-feeding?
    No clear data is available about the presence of this medicine in the human breast milk. Consult your doctor about the potential benefits and risks before deciding to take this medicine.

Allergy

This medicine is not recommended in the patients with known history of allergy to Fabuzest 40 MG Tablet.
Warnings for special population

Pregnancy

This medicine is not recommended for use during pregnancy unless absolutely necessary. Consult your doctor about the potential benefits and risks before deciding to take this medicine.

Breast-feeding

No clear data is available about the presence of this medicine in the human breast milk. Consult your doctor about the potential benefits and risks before deciding to take this medicine.
General warnings

Gout flare

Gout flares may occur after initiation of the treatment due to change in the serum uric acid levels. Discontinue the treatment until the symptoms completely subsided. Simultaneously gout flare prophylaxis with nonsteroidal anti-inflammatory drugs or colchicine should be initiated for up to 6 months.

Cardiovascular events

This medicine in not recommended in the patients with ischemic heart disease due to the risk of cardiovascular thromboembolic events like myocardial infarction, stroke.

Impaired liver function

This medicine is known to cause liver failure. Obtain baseline of liver function tests before initiation of the treatment. The treatment should be discontinued if the alanine aminotransferase (ALT) is greater than 3 times the reference range.

Impaired kidney function

This medicine should be used with caution in the patients with severe kidney injury (CrCl less than 30 ml/min).

Asymptomatic hyperuricemia

This medicine is not recommended for use in the patients with asymptomatic hyperuricemia.

Missed Dose

Take the missed dose as soon as you remember. However, if it is almost time for the next scheduled dose then the missed dose should be skipped.

Overdose

Contact a doctor immediately if an overdose is suspected. Symptoms of overdose may include a change in pulse rates, severe drowsiness, confusion, vomiting, hallucinations, convulsions, and fainting. Immediate medical intervention may be required if the overdose symptoms are severe.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Azathioprine

Theophylline

Disease interactions

Secondary Hyperuricemia

This medicine is not recommended in the patients with malignant disease, tumor lysis syndrome or Lesch-Nyhan syndrome where uric acid levels are highly elevated.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Fabuzest 40 MG Tablet as prescribed by the doctor. Do not take this medicine in larger or smaller quantities than recommended. The treatment should be started at lower doses and increase the dose gradually based on the response. Do not stop taking this medicine without informing your doctor.
Miscelleneous

Food timings: Information not available

Administration time: Information not available

Sleep inducing: Information not available

How it works
It works by inhibiting the production of uric acid in the body.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Antigout agents

Schedule

Schedule H

Febuxostat: Indications, Side Effects, Warnings - Drugs.com [Internet]. Drugs.com. 2017 [cited 11 April 2017]. Available from:

https://www.drugs.com/cdi/febuxostat.html

[Internet]. 2017 [cited 11 April 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/30332

Febuxostat: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 11 April 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a609020.html

DailyMed - ULORIC- febuxostat tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 11 April 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=54de10ef-fe5f-4930-b91d-6bbb04c664bd#section-8.1

Uloric (febuxostat) dosing, indications, interactions, adverse effects, and more [Internet]. Reference.medscape.com. 2017 [cited 11 April 2017]. Available from:

http://reference.medscape.com/drug/uloric-febuxostat-345048
Loading related questions...

How will this medicine affect me?

Chat with verified doctors starting @ ₹99
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Something doesn’t feel right?
Report an error

Information on this page was last updated on 18 Apr 2017

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C  here.